After a review of the totality of information, including all clinical data generated to date for danuglipron and recent input from regulators, Pfizer has decided to discontinue development of the molecule
Persistent or excessive thirst (polydipsia) may indicate inadequate diabetes control, particularly if blood glucose levels remain elevated despite treatment
To determine the subtype selectivity of exendin 939, we tested its effect on TRPA1
At least 11 semaglutide drug candidates from Chinese firms are in the final stages of clinical trials, according to records in a clinical trial database reviewed by Reuters
Business Type Manufacturer, Distributor, Supplier Employee Count 50 Establishment 2011 Working Days To GST NO 06AAHCM5807H1ZG Related Products Explore Related Categories More Products From This Seller Seller Details GST - 06AAHCM5807H1ZG Trusted Seller Barwala, Haryana Marketing Manager Mr